These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23101492)

  • 1. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
    Hien TT; Thuy-Nhien NT; Phu NH; Boni MF; Thanh NV; Nha-Ca NT; Thai le H; Thai CQ; Toi PV; Thuan PD; Long le T; Dong le T; Merson L; Dolecek C; Stepniewska K; Ringwald P; White NJ; Farrar J; Wolbers M
    Malar J; 2012 Oct; 11():355. PubMed ID: 23101492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
    Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
    Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of dihydroartemisinin/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam.
    Rovira-Vallbona E; Van Hong N; Kattenberg JH; Huan RM; Hien NTT; Ngoc NTH; Guetens P; Hieu NL; Mai TT; Duong NTT; Duong TT; Phuc BQ; Xa NX; Erhart A; Rosanas-Urgell A
    J Antimicrob Chemother; 2020 Aug; 75(8):2272-2281. PubMed ID: 32437557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.
    Thanh NX; Trung TN; Phong NC; Quang HH; Dai B; Shanks GD; Chavchich M; Edstein MD
    Malar J; 2012 Jun; 11():217. PubMed ID: 22741618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam.
    Thriemer K; Hong NV; Rosanas-Urgell A; Phuc BQ; Ha do M; Pockele E; Guetens P; Van NV; Duong TT; Amambua-Ngwa A; D'Alessandro U; Erhart A
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7049-55. PubMed ID: 25224002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
    Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
    Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
    Lek D; Rachmat A; Harrison D; Chin G; Chaoratanakawee S; Saunders D; Menard D; Rogers WO
    Malar J; 2022 Sep; 21(1):259. PubMed ID: 36071520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
    Das D; Tripura R; Phyo AP; Lwin KM; Tarning J; Lee SJ; Hanpithakpong W; Stepniewska K; Menard D; Ringwald P; Silamut K; Imwong M; Chotivanich K; Yi P; Day NP; Lindegardh N; Socheat D; Nguon C; White NJ; Nosten F; Dondorp AM
    Clin Infect Dis; 2013 Mar; 56(5):e48-58. PubMed ID: 23175556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
    van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
    Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.
    Amaratunga C; Sreng S; Suon S; Phelps ES; Stepniewska K; Lim P; Zhou C; Mao S; Anderson JM; Lindegardh N; Jiang H; Song J; Su XZ; White NJ; Dondorp AM; Anderson TJ; Fay MP; Mu J; Duong S; Fairhurst RM
    Lancet Infect Dis; 2012 Nov; 12(11):851-8. PubMed ID: 22940027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
    Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisinin resistance in Plasmodium falciparum malaria.
    Dondorp AM; Nosten F; Yi P; Das D; Phyo AP; Tarning J; Lwin KM; Ariey F; Hanpithakpong W; Lee SJ; Ringwald P; Silamut K; Imwong M; Chotivanich K; Lim P; Herdman T; An SS; Yeung S; Singhasivanon P; Day NP; Lindegardh N; Socheat D; White NJ
    N Engl J Med; 2009 Jul; 361(5):455-67. PubMed ID: 19641202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan.
    Mohamed AO; Abdel Hamid MM; Mohamed OS; Elkando NS; Suliman A; Adam MA; Elnour FAA; Malik EM
    Malar J; 2017 Apr; 16(1):163. PubMed ID: 28427409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
    Kyaw MP; Nyunt MH; Chit K; Aye MM; Aye KH; Aye MM; Lindegardh N; Tarning J; Imwong M; Jacob CG; Rasmussen C; Perin J; Ringwald P; Nyunt MM
    PLoS One; 2013; 8(3):e57689. PubMed ID: 23520478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
    ; Abdulla S; Ashley EA; Bassat Q; Bethell D; Björkman A; Borrmann S; D'Alessandro U; Dahal P; Day NP; Diakite M; Djimde AA; Dondorp AM; Duong S; Edstein MD; Fairhurst RM; Faiz MA; Falade C; Flegg JA; Fogg C; Gonzalez R; Greenwood B; Guérin PJ; Guthmann JP; Hamed K; Hien TT; Htut Y; Juma E; Lim P; Mårtensson A; Mayxay M; Mokuolu OA; Moreira C; Newton P; Noedl H; Nosten F; Ogutu BR; Onyamboko MA; Owusu-Agyei S; Phyo AP; Premji Z; Price RN; Pukrittayakamee S; Ramharter M; Sagara I; Se Y; Suon S; Stepniewska K; Ward SA; White NJ; Winstanley PA
    Malar J; 2015 Sep; 14():359. PubMed ID: 26390866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
    Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
    Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
    Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
    Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
    Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.